Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 9/2014

01-09-2014 | GI Image

Giant Adrenal Myelolipoma

Authors: Juan F. Alvarez, Lindsey Goldstein, Naziya Samreen, Richard Beegle, Christopher Carter, Ana Shaw, Kfir Ben-David

Published in: Journal of Gastrointestinal Surgery | Issue 9/2014

Login to get access

Excerpt

A 44-year-old Caucasian woman presented to the emergency department for an evaluation of 5 days of progressive abdominal distention, nausea, and bilious emesis. The patient’s medical history was notable for congenital virilizing adrenal hyperplasia resulting in pseudohermaphroditism. She reported a remote treatment with steroid therapy terminated in adolescence due to poor medical follow up due to depression related to her gender identity. Upon discontinuation of her therapy, she gradually manifested male phenotype resulting in male pattern baldness, coarse facial hair, and a baritone voice. Physical exam was notable for a firm, non-tender, distended abdomen, hirsutism, and ambiguous genitalia. A contrast-enhanced computed tomographic (CT) scan was obtained demonstrating a very large, 26 cm × 24 cm × 9.5 cm, left-sided retroperitoneal mass of unclear origin and a right lower quadrant small bowel obstruction with pneumatosis (Fig. 1). The patient was taken emergently for an exploratory laparotomy with complete excision of the retroperitoneal mass and reduction of a closed loop small bowel obstruction. Pathologic examination of the mass resulted as a giant adrenal myelolipoma measuring up to 34 cm in its largest diameter and weighing 5,090 g (Fig. 2a, b).
Literature
1.
go back to reference Perez Martinez J, Llamas F, Lopez Rubio E, Serrano A, Salinas Sánchez A, Ruiz Mondéjar R, et al. Giant adrenal myelolipoma: Hypertension, renal failure and spontaneous rupture. Nefrologia. 2006;26:132PubMed Perez Martinez J, Llamas F, Lopez Rubio E, Serrano A, Salinas Sánchez A, Ruiz Mondéjar R, et al. Giant adrenal myelolipoma: Hypertension, renal failure and spontaneous rupture. Nefrologia. 2006;26:132PubMed
2.
go back to reference Daneshmand S, Quek ML. Adrenal myelolipoma: Diagnosis and management. J Urol. 2006;3:71–74 Daneshmand S, Quek ML. Adrenal myelolipoma: Diagnosis and management. J Urol. 2006;3:71–74
3.
go back to reference Meaglia JP, Schmidt JD. Natural history of an adrenal myelolipoma. J Urol. 1992;147:189–1090 Meaglia JP, Schmidt JD. Natural history of an adrenal myelolipoma. J Urol. 1992;147:189–1090
4.
go back to reference Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 2008;190:1163–1168PubMedCrossRef Song JH, Chaudhry FS, Mayo-Smith WW. The incidental adrenal mass on CT: Prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 2008;190:1163–1168PubMedCrossRef
5.
go back to reference Akamatsu H, Koseki M, Nakaba H, et al. Giant adrenal myelolipoma: report of a case. Surg Today. 2004;34:283–5PubMedCrossRef Akamatsu H, Koseki M, Nakaba H, et al. Giant adrenal myelolipoma: report of a case. Surg Today. 2004;34:283–5PubMedCrossRef
6.
go back to reference G. Low, H. Dhliwayo, D.J. Lomas. Adrenal neoplasms. Clinical Radiology. Volume 67, Issue 10, October 2012, Pages 988–1000 G. Low, H. Dhliwayo, D.J. Lomas. Adrenal neoplasms. Clinical Radiology. Volume 67, Issue 10, October 2012, Pages 988–1000
7.
go back to reference Rao P, Kenney PJ, Wagner BJ, Davidson AJ. Imaging and pathologic features of myelolipoma. Radiographics. 1997 17(6):1373–85PubMedCrossRef Rao P, Kenney PJ, Wagner BJ, Davidson AJ. Imaging and pathologic features of myelolipoma. Radiographics. 1997 17(6):1373–85PubMedCrossRef
8.
go back to reference Wagnerova H, Lazúrová I, Habalová V, Dudásová D, Vrzgula A. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas hormonal and mutation screening. Exp Clin Endocrinol Diabetes. 2008;116:272–5.PubMedCrossRef Wagnerova H, Lazúrová I, Habalová V, Dudásová D, Vrzgula A. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas hormonal and mutation screening. Exp Clin Endocrinol Diabetes. 2008;116:272–5.PubMedCrossRef
9.
go back to reference Hagiwara H, Usui T, Kimura T, Tagami T, Naruse M, Minamiguchi S,et al. Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr Pathol. 2008;19:122–7.PubMedCrossRef Hagiwara H, Usui T, Kimura T, Tagami T, Naruse M, Minamiguchi S,et al. Lack of ACTH and androgen receptor expression in a giant adrenal myelolipoma associated with 21-hydroxylase deficiency. Endocr Pathol. 2008;19:122–7.PubMedCrossRef
10.
go back to reference Russell C, Goodacre BW, VanSonnenberg E, Orihuela E. Abdom Imaging. 2000 Jul-Aug;25(4):431–4. Russell C, Goodacre BW, VanSonnenberg E, Orihuela E. Abdom Imaging. 2000 Jul-Aug;25(4):431–4.
Metadata
Title
Giant Adrenal Myelolipoma
Authors
Juan F. Alvarez
Lindsey Goldstein
Naziya Samreen
Richard Beegle
Christopher Carter
Ana Shaw
Kfir Ben-David
Publication date
01-09-2014
Publisher
Springer US
Published in
Journal of Gastrointestinal Surgery / Issue 9/2014
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-014-2553-x

Other articles of this Issue 9/2014

Journal of Gastrointestinal Surgery 9/2014 Go to the issue